Gynesonics Logo.jpg
Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids
September 26, 2024 08:30 ET | Gynesonics
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...
U.S. Women’s Health Market
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
September 20, 2024 04:04 ET | Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
22157.jpg
United States Endometriosis and Uterine Fibroids Markets, 2020-2024 & 2025-2030: Rise in Non-Invasive Drug Therapies Driving Growth, Online Pharmacies Set to Revolutionize Distribution
September 19, 2024 07:25 ET | Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type, By Route of Administration, By Distribution Channel, By...
22157.jpg
Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie
September 18, 2024 04:14 ET | Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Women Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...
22157.jpg
Gynecology Drugs Market Trends and Business Opportunities, Worldwide, 2024-2029
August 26, 2024 09:44 ET | Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Gynesonics Logo.jpg
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
August 20, 2024 10:30 ET | Gynesonics
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
U.S. Women’s Health Market
United States Women's Health Market, By Region, Competition, Forecast and Opportunities, 2019-2029F
July 09, 2024 10:39 ET | Research and Markets
Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "United States Women's Health Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Ted-Stephens-300x300
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
March 19, 2024 10:00 ET | Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Logo.jpg
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
January 02, 2024 11:13 ET | Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Logo.jpg
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 02, 2023 09:41 ET | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure